(SMMT) Summit Therapeutics - Performance 431.4% in 12m
Compare SMMT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
56.63%
#12 in Group
Rel. Strength
99.71%
#23 in Universe
Total Return 12m
431.43%
#4 in Group
Total Return 5y
763.29%
#3 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -0.98%
43th Percentile in Group
12m Total Return: SMMT (431.4%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: SMMT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SMMT
| Total Return (including Dividends) | SMMT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.95% | -5.85% | -3.01% |
| 3 Months | 11.50% | -11.95% | -3.15% |
| 12 Months | 431.43% | -11.00% | 10.19% |
| 5 Years | 763.29% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | SMMT | XBI | S&P 500 |
| 1 Month | 45.3% | -59.8% | -5.5% |
| 3 Months | 10.7% | -70.5% | -58.4% |
| 12 Months | 77.4% | -6.9% | 84.1% |
| 5 Years | 17.1% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #33 | 13.6% | 10.3% |
| 3 Month | #26 | 26.6% | 15.1% |
| 12 Month | #3 | 497% | 382% |
| 5 Years | #3 | 758% | 277% |
FAQs
Does SMMT Summit Therapeutics outperforms the market?
Yes,
over the last 12 months SMMT made 431.43%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months SMMT made 11.50%, while XBI made -11.95%.
Over the last 3 months SMMT made 11.50%, while XBI made -11.95%.
Performance Comparison SMMT vs Indeces and Sectors
SMMT vs. Indices SMMT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.59% | 9.96% | 4.84% | 421% |
| US NASDAQ 100 | QQQ | 4.57% | 11.0% | 5.61% | 423% |
| US Dow Jones Industrial 30 | DIA | 3.39% | 9.09% | 3.92% | 422% |
| German DAX 40 | DAX | 4.89% | 10.3% | -12.0% | 410% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.88% | 6.72% | 20.1% | 422% |
| Hongkong Hang Seng | HSI | 1.62% | 4.18% | 14.1% | 414% |
| India NIFTY 50 | INDA | 2.56% | -0.92% | 15.2% | 431% |
| Brasil Bovespa | EWZ | 3.48% | -1.34% | 12.8% | 443% |
SMMT vs. Sectors SMMT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.13% | 10.8% | -3.27% | 412% |
| Consumer Discretionary | XLY | 2.83% | 10.8% | 1.48% | 417% |
| Consumer Staples | XLP | 0.80% | 8.79% | 4.0% | 420% |
| Energy | XLE | 2.50% | -1.07% | -0.74% | 431% |
| Financial | XLF | 3.11% | 9.65% | -7.32% | 409% |
| Health Care | XLV | 3.17% | 10.1% | 9.54% | 430% |
| Industrial | XLI | 3.28% | 7.64% | 5.55% | 423% |
| Materials | XLB | 2.49% | 6.44% | 13.0% | 435% |
| Real Estate | XLRE | 1.55% | 9.64% | 7.96% | 418% |
| Technology | XLK | 4.72% | 11.0% | 9.96% | 429% |
| Utilities | XLU | 0.30% | 6.13% | 5.72% | 406% |
| Aerospace & Defense | XAR | 4.19% | 5.67% | 0.92% | 411% |
| Biotech | XBI | 8.15% | 12.8% | 22.5% | 442% |
| Homebuilder | XHB | 3.09% | 6.80% | 24.2% | 439% |
| Retail | XRT | 1.29% | 7.45% | 8.92% | 436% |